A cost-effectiveness analysis of a 10-valent pneumococcal conjugate vaccine in children in six Latin American countries

201342 citationsJournal Articlegold Open Access

Authors

Sebastián García Martí · Instituto de Efectividad Clínica y Sanitaria

Lisandro D. Colantonio · Instituto de Efectividad Clínica y Sanitaria

Ariel Bardach · Instituto de Efectividad Clínica y Sanitaria

Julieta Galante · Instituto de Efectividad Clínica y Sanitaria

Analía López · Instituto de Efectividad Clínica y Sanitaria

Joaquín Caporale · Instituto de Efectividad Clínica y Sanitaria

Abstract

The incorporation of the 10-valent pneumococcal conjugate vaccine into routine infant immunization programs in Latin American countries could be a cost-effective strategy to improve infant population health in the region.

Topics & Keywords

Pneumonia and Respiratory Infections Bacterial Infections and Vaccines Respiratory viral infections research

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Cost Effectiveness and Resource Allocation

Volume 11, Issue 1, pp. 21-21

DOI: 10.1186/1478-7547-11-21

Field-Weighted Citation Impact: 2.44